Compass Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.89 |
4.66 |
22.35 |
101.77 |
209.86 |
362.31 |
| Przychód Δ r/r |
0.00% |
424.53% |
379.35% |
355.33% |
106.22% |
72.64% |
| Przychód (min) |
0.86 |
3.08 |
22.35 |
101.77 |
138.41 |
238.95 |
| Przychód (max) |
0.91 |
6.25 |
22.35 |
101.77 |
281.31 |
485.66 |
| EBITDA (średnia) |
0.53 |
2.80 |
13.41 |
61.06 |
125.92 |
217.38 |
| EBIT (średnia) |
0.53 |
2.80 |
13.41 |
61.06 |
125.92 |
217.38 |
| EBIT % |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-49.50 |
-68.69 |
-94.55 |
-51.09 |
40.54 |
115.63 |
| Zysk netto % |
-5568.69% |
-1473.27% |
-423.05% |
-50.21% |
19.32% |
31.91% |
| EPS (średnia) |
-0.35 |
-0.50 |
-0.56 |
-0.28 |
0.30 |
0.84 |
| Liczba analityków (Przychody) |
8 |
6 |
10 |
10 |
4 |
5 |
| Liczba analityków (EPS) |
8 |
7 |
8 |
10 |
5 |
4 |
| symbol |
CMPX |
CMPX |
CMPX |
CMPX |
CMPX |
CMPX |